Clinical Trials Logo

Clinical Trial Summary

The study examines the possible effect of a community campaign to decrease the duration of untreated psychosis in persons with their first episode of a psychotic disorder.


Clinical Trial Description

The study examines whether a community campaign can reduce over time the duration of untreated psychosis (DUP) among persons with first episode psychosis (FEP). The DUP of mental health patients with FEP who sought services at a public outpatient or an inpatient facility was assessed for a 15 month period prior to the campaign launch. This serves as the baseline or historical control. The DUP will continue to be assessed for another 3 years. The hypothesis being tested is that there will be a significant decrease in DUP between baseline, one-year, two-year and three-year follow-ups. This study is being carried out with Latinos in Los Angeles County because as a group, particularly among Spanish-speaking immigrants, Latinos are at high risk for prolonged DUP. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03102151
Study type Observational
Source University of Southern California
Contact
Status Completed
Phase
Start date May 2014
Completion date August 30, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT04298450 - ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention N/A
Completed NCT00202280 - Efficacy of Treating First Episode Psychosis With Folic Acid,B12 and B6 in Addition to Antipsychotic Medication Phase 2/Phase 3
Completed NCT01026584 - Efficacy and Safety of Aripiprazole in First Episode Psychosis Phase 4
Completed NCT03983421 - Feasibility of an Early Detection Program for Early Psychosis on a College Campus
Recruiting NCT04046497 - Artificial Intelligence to Measure Adherence to Oral Medication Phase 4
Withdrawn NCT04369677 - Thermoregulation Among Individuals With First-episode Psychosis
Completed NCT03568500 - A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic Phase 4
Completed NCT00916461 - Role of Minocycline in First Episode Psychosis Phase 1/Phase 2
Recruiting NCT05310838 - Optimizing Engagement in Services for First-Episode Psychosis N/A
Completed NCT03501160 - Socially Inappropriate Behaviour in People With First Episode Psychosis: A Caregivers' Perspective
Recruiting NCT03196128 - Early Intervention Psychosis Communication and Engagement Trial N/A
Recruiting NCT04005378 - Disengagement in CSC: Identifying Those at Risk and Addressing Their Needs Phase 4
Recruiting NCT03919760 - Early Psychosis Intervention - Spreading Evidence-based Treatment
Completed NCT03409393 - Feasibility and Relevance of High-Intensity Functional Training in Patients With First-Episode Psychosis N/A
Completed NCT01753284 - First Episode Psychosis and Pathway to Care in Nordland
Completed NCT01157585 - Efficacy and Safety of Paliperidone ER in First Episode Psychosis Phase 4
Completed NCT05737966 - Evaluation of Case Management for First Episode Psychosis Using the PEPsy-CM Checklist
Recruiting NCT04021719 - OnTrackNY's Learning Healthcare System
Recruiting NCT04889911 - Pilot RCT of Self-stigma Treatment for First Episode Psychosis N/A
Recruiting NCT04853485 - Repetitive Transcranial Magnetic Stimulation in Early Psychosis and The Functional Connectivity Biotypes N/A